Recommended

Register now: Enhancing biopharma workflows with the power of UV/Vis spectroscopy webinar
Download our brand new eBook: A practical guide to single-use filtration in biopharma.
Join us as we look at how the outsourcing of buffers is helping biopharma drug manufacturers to streamline their processes.
Discover more on how Polpharma API meets evolving regulatory guidance around N-nitrosamines control in APIs with Waters’ high-performance analysis instruments.
Learn more about leveraging real-world data, the practical applications of AI and adopting configurable LC/NC solutions.
Download this compendium to discover how hot-melt extrusion can help to overcome pharmaceutical formulation challenges
article

Spotlight on… Continuous Manufacturing

Welcome to European Pharmaceutical Review’s Spotlight on Continuous Manufacturing.

Continuous Manufacturing cover 2018

In this special section:

We highlight how some of the key suppliers to the pharmaceutical sector are collaborating on a number of industry projects that are helping to facilitate the uptake of CM technology in the drug production sector.

Roundtable on Continuous Manufacturing:
We have brought together six of the industry’s leading experts to discuss on how the contribution of continuous manufacturing technology is shaping the pharmaceutical sector and explain what factors are driving that change.

Taking part in this Roundtable are:

  • Dennis Powers, Vice President of Business Development & Sales Engineering, G-CON Manufacturing, Inc.
  • Richard Steiner, Business Development Manager for continuous, oral solid dosage (OSD) systems, GEA
  • Marco Bellentani, Product Manager for Containment and Innovative Solutions, MG2
  • David Lovett, Co-founded and Managing Director of Perceptive Engineering Ltd
  • Massimo Bresciani, R&D Executive Director, Business Development and Scientific Operation, RCPE
  • Jan Verelst, Global Business Development Manager for SIPAT, Siemens

Supplier Profiles:

GEA; Siemens; G-COM; MG2; Perceptive Engineering Ltd; RCPE

This supplement is restricted - login or subscribe free to access

EPR Issue 1 2024Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • bi-monthly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here